William Blair & Company
NVRO

William Blair & Company’s NEVRO CORP. NVRO Stock Holding History

William Blair & Company’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,900
Closed -$216K – 1534
2017
Q2 		$216K Buy
2,900
+1,300
+81% +$104K ﹤0.01% 1308
2017
Q1 		$150K Buy
+1,600
New +$145K ﹤0.01% 1260

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company's NVRO Position: Q1 2025 in Review

William Blair & Company sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 37,829 shares — an estimated $141K sold.

William Blair & Company first reported a position in NVRO in Q3 2016 and held it in 34 quarters. The position peaked at $27.9M in Q3 2016. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • William Blair & Company reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • William Blair & Company sold 37,829 NEVRO CORP. shares in Q1 2025, an estimated $141K.
  • William Blair & Company first reported a position in NEVRO CORP. in Q3 2016 and held it in 34 quarters.
  • William Blair & Company's NEVRO CORP. position peaked at $27.9M in Q3 2016.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on William Blair & Company's 13F filing for Q1 2025, filed 9 May 2025.